A randomised controlled trial of potential for pharmacologic prevention of new-onset albuminuria, hypertension and diabetes in a remote Aboriginal Australian community, 2008–2013

INTRODUCTION: We conducted a double-blind randomised controlled trial in a remote-living Australian Aboriginal group at high risk for chronic disease to assess whether pharmacological treatment with angiotensin converting enzyme inhibitor (ACEi) could delay the onset of albuminuria, hypertension or...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoy, Wendy E., Reid, Christopher M., Huq, Molla, McLeod, Beverly J., Mott, Susan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348198/
https://www.ncbi.nlm.nih.gov/pubmed/30705994
http://dx.doi.org/10.1016/j.conctc.2019.100323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348198/
https://www.ncbi.nlm.nih.gov/pubmed/30705994
http://dx.doi.org/10.1016/j.conctc.2019.100323

Ejemplares similares